Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-26-070025

EVP, General Counsel, Corp Sec sold 3,750 shares at an average $11.18 ($41,939)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
de Verneuil Vanina EVP, General Counsel, Corp Sec 2026-11-02 Sale 10b5-1 −1,343 $11.33 $15,222 112,600 D
de Verneuil Vanina EVP, General Counsel, Corp Sec 2026-11-03 Sale 10b5-1 −2,407 $11.10 $26,718 110,193 D
Open-market sales · 3,750 sh · avg $11.18 · $41,939
Loading xslF345X06/wk-form4_1793822169.xml…